Platelet-Rich Plasma (PRP) is a biological product often used to promote tissue repair, due to its composition of growth factors. The aim of this study was to compare the viability of platelets on horses and mules and the influence of two different anticoagulantsddextrose citrate (ACD) and sodium citrate (CIT)dwhile obtaining PRP. Eight horses and eight mules were used, with two replicas each. PRP was obtained after single centrifugation at 133 g for 8 minutes. Blood analysis was performed on hematologic analyzer, and morphology was evaluated through optical microscopy of phase inversion. Platelet concentration on PRP (when compared with total blood samples) was 1.42 times in horses and 2.0 times in mules using ACD, and 1.39 times in horses and 2.69 times in mules using CIT. The protocol was more efficient in concentrating mules' platelets when compared with horses', and CIT was responsible for a larger PRP leukocyte reduction on both equids. CIT was a better anticoagulant for mules' PRP procurement, due to its promotion of higher platelet concentration.
Introduction
Platelet-Rich Plasma (PRP) is a biological product, often used to promote tissue repair due to growth factors (GFs) in its composition. GFs are paramount on healing processes because they are able to modulate several cellular activities. PRP therapy has advantages over conventional ones, thus promoting a personalized treatment, as well as incurring on minimally invasive procedures, promoting acceleration of functional tissue repair and offering low risks due to its autologous nature [1, 2] .
PRP is considered a promising regenerative therapy in both human and equine medicine. In horses, PRP is already labeled as efficient on reducing pain and effusion after its intra-articular use [3] , in damaged soft tissues of the locomotor system [4] and even in laminitis cases [5] . However, literature is poor regarding the particularities of mules' platelets and protocols for obtaining PRP from this equid. Mules are hybrid animals, having intermediate physical and behavioral characteristics from their progenitors: mare (Equus caballus) and donkey (Equus asinus) [6] . The particularities of this hybrid may as well be extended to its hematological parameters and metabolism, which can directly affect PRP quality and its therapeutic efficiency.
Choice of anticoagulant is paramount for PRP quality. Ethylenediaminetetraacetic acid (EDTA) is not recommended for PRP acquisition, due to its platelet fragmentation ability and overestimation of the total platelet count (PLT) in the compound [7] . Therefore, some anticoagulants are preferable for PRP procurement, such as acid citrate dextrose (ACD) solution A or B and sodium citrate (CIT). They are ideal anticoagulants for PRP because they are able to prevent platelet activation and maintain the integrity and functional reserve of these cells [8] .
The aim of the present study is to compare PRP quality between horses and mules and the influence of the two anticoagulants: ACD solution A and CIT, on PRP hematological parameters and platelet morphology.
Material and Methods

Horses and Mules
Sixteen clinically normal horses and mules were used (eight of each equid group). A duplicate was performed 1 week after the first blood sampling of each animal. All animals lived inside the Veterinary Medical Teaching Hospital of the Federal University of Minas Gerais and were fed and managed under the same conditions.
Blood Sampling
A total of nine tubes were collected from each animal's jugular vein. One of EDTA (4.0 mL), five of 3.2% CIT (4.5 mL each), and three of ACD (8.5 mL each) (BD Vacutainer systems, Juiz de Fora, Brazil), all using needle for blood withdraw.
Single Centrifugation Tube Method
Samples collected in ACD and CIT were immediately centrifuged (Cientec CT-6000R), under a single centrifugation protocol of 133 g for 8 minutes, using 30-second acceleration and 120-second braking as described by Fantini et al. [9] . PRP was then aspirated 4 mm over the buffy coat, using a 14G catheter and 3.0 mL syringe. From ACD tubes (8.5 mL of total volume), 1.0 mL of PRP was aspirated; from CIT tubes (4.5 mL of total volume), 0.6 mL of PRP was aspirated. The average time between extraction and the beginning of sample processing was 30 minutes.
Platelet and Leukocyte Count
A complete blood test was performed for each sample (EDTA, ACD, and CIT) using an automated blood cell count (pocH-100Iv-Diff) and a Veterinary Package calibrated for equine blood parameters. PRP also underwent automated cell count. Hematological parameters evaluated included packed cell volume (PCV), red blood cell count (RBC), PLT, total white cell count (WBC), as well as the relative and absolute numbers of lymphocytes and the sum of the other WBC cells, values of mean platelet volume (MPV), platelet distribution width (PDW), and platelet clumps.
Platelet Morphology Analysis
Morphology analysis was performed by an optical microscopy of phase inversion (Olympus CBA, Tokyo, Japan). On the surface of a microscope slide, 10 mL of PRP, 10 mL of 10% formal saline, and 10 mL Ress-Eckert (Laborclin, Pinhais, Paran a, Brazil) were homogenized and covered with a glass slide. All corners of the slide were sealed with nail polish. Morphology analysis took place on a 1,000Â magnification lens, using oil for immersion. Platelets were then classified as resting, uncertain, or inactivated state, according to the classification proposed by Würzinger and SchmidSchonbein [10] . Platelets considered on resting state were elongated and of oval shape. Platelets classified as in an uncertain state were round ones, with membrane integrity. Platelets in an activated state were those with pseudopod emission.
Statistical Analysis
Data were analyzed using SAS software (2002) and tested for normality of distribution using the ShapiroeWilk (SW) test. Variables presented nonparametric distribution (SW < 0.05) even after transformation by Arcsen √x or Log (x þ 1). Means were compared using KruskaleWallis test (three or more comparisons) or by Table 1 Mean values ± standard error of hematologic parameters on total blood (EDTA, ACD, CIT) and PRP obtained from two anticoagulants (ACD and CIT) and from two equids (mules and horses). Hematological /mL).
Means followed by different letters on the same line differ (P < .05).
Wilcoxon test (two comparisons). A Spearman correlation test was also performed. A P < .05 value was accepted as a statistically significant difference for all tests.
Results
Results of hematological characteristics of PRP obtained from horses and mules using CIT and ACD as anticoagulants are described in Table 1 . Variables such as PCV, hemoglobin, mean corpuscular volume, and red blood cell distribution width were removed from the table due to its lack of effect on PRP. However, RBC was maintained due to its significant difference (P < .05) between the evaluated groups. The anticoagulant, however, did not influence this parameter. The PRP obtained was nominated Pure-PRP according to the classification given by Ehrenfest et al. [11] .
The PRP protocol was able to concentrate more platelets on mules: 2.0 times using ACD and 2.69 times using CIT. On horses, the concentration was of 1.42 times using ACD as anticoagulant and 1.39 times using CIT (Fig. 1) . The anticoagulant did not significantly influence platelet concentration when evaluated within each equid group.
White blood cell count reduction was significant on all equids and anticoagulants used. There was a 5.44 times reduction on ACD and a 34.9 times reduction on CIT, both on horses. Mules had a WBC reduction of 5.62 times on ACD and 15.8 times on CIT. CIT was more efficient in reducing PRP's WBC in comparison with ACD (Fig. 2) .
Despite the small number of samples, the Spearman correlation showed some interesting results. On total blood samples collected on ACD, PLT had a positive and significant (P < .05) correlation with WBC on horses (0.67) and mules (0.86), not observed on CIT. On PRP samples, PLT had a negative and significant correlation (P < .05) with WBC only on mules and using CIT (À0.66).
Morphology analysis (Fig. 3) is described in Table 2 . Platelets classified as in a resting or uncertain state were summed together, due to the possibility of the uncertain state be reversed into the resting one. There was no significant difference (P < .05) on PRP platelet activation, regardless of the equid group or anticoagulant used. The percentage of cells in uncertain and resting state was larger, both on horses and mules, in comparison with the activated one.
Discussion
PRP is defined as a compound having a significantly higher PLT than that of total blood [4] . Marx [12] highlights that this concentration must be at least four to five times higher. However, Fontenot et al. [13] explain that equine PLT is one of the lowest among mammals and that many PRP platelet parameters originate from researches using human blood. These authors also suggest that such established values (using human blood as a parameter) should not be taken into consideration when dealing with equine PRP. They also highlighted the uniqueness of equine platelet physiology of granules release and GF content, which is totally distinct from humans' [13e15]. Baksh et al. [16] performed a review on PRP use in tendon models and found PRP platelet concentration ranging from 1.5 to 10 times of that of total blood, a difference explained by the multitude of processual protocols available. Therefore, PRP samples are unique because there are different acquisition protocols, which may be accountable for the different therapeutic efficiencies described [16, 17] . There is a consensus, however, that singlecentrifugation protocols, with lower rotations per minute (rpm), can concentrate platelets from two to three times from total blood and may also drastically decrease WBC count [18] . Both characteristics were observed on the protocol used in the present study, providing a platelet concentration ranging from 1.39 to 2.69 times and a decrease of WBC ranging from 5.44 to 34.9 times.
The lack of influence of the anticoagulant on PRP's platelet concentration within the equids of the present study agrees with Giraldo et al. [19] , who tested the effect of the anticoagulants ACD-A, ACD-B, and CIT on PLT and release of GF on horses' PRP. However, in the present study, larger PDW and MPV were observed on CIT in comparison with ACD, differences not observed by Giraldo et al. [19] . In a similar study using bovine PRP, Carmona et al. [20] obtained a 2.3 and 2.5 times platelet concentration when compared with total blood, using CIT and ACD-A, respectively. In the present study, mules had a 2.0 times platelet concentration using ACD and 2.69 times using CIT. Horses, however, presented lower concentrations regardless of the anticoagulants employed (1.42 times in ACD and 1.39 times in CIT). In the present study, WBC presented a negative correlation with PLT (À0.66) on mules' PRP using CIT as anticoagulant, agreeing with the most dramatic WBC reduction observed in this equid and anticoagulant. No other correlations between these variables were observed on ACD or on horses.
Gardner [21] was one of the first authors to highlight the importance of a proper anticoagulant for platelets. After the discovery of ACD-A, this author stresses that 80% of platelets could be recovered for posterior transfusion, with a concomitant reduction of clump formation, a percentage never attained when using other anticoagulants available. The same author also describes a better platelet aggregation control during centrifugation when using CIT. Mody et al. [8] highlight that an ideal anticoagulant must prevent platelet activation for as long as possible and should not interfere with laboratorial analysis. These authors also mentioned that an anticoagulant must aid in maintaining a platelet functional reserve, thus contributing for their long-lasting integrity. Marx [7] explains that EDTA is not suitable for platelet viability because this anticoagulant has the capacity to fragment platelets, disturbing their integrity, and overestimating their count on the acquired PRP. Such overestimated PLT on EDTA was observed in the present study. Ahnadi et al. [22] observed platelets under transmission electron microscopy and concluded that platelets harvested from EDTA were in a more activated state and with fewer granules, when compared with samples obtained from citrate theophylline adenosine dipyridamole.
White blood cell count significant reduction on both equids and anticoagulants can be explained by the protocol used, based on single centrifugation. Single centrifugation is a protocol well known for its technical simplicity, less processual error susceptibility, and smaller capacity in concentrating WBC in comparison with double centrifugation protocols [23, 24] . There is, however, a lot of speculation around the role of leukocytes on PRP composition. Nagata et al. [22] explain that leukocytes have the ability to release proteases and reactive oxygen, which would promote a premature release of GF. Filardo et al. [24] report inflammatory adverse reactions in human patients with osteoarthritis who had undergone intra-articular injections of PRP containing leukocytes in its composition. McCarrel et al. [25] report the negative effect of leukocytes on tendons explants due to WBC contribution to inflammatory cytokines expression, such as interleukin-1 beta and tumor necrosis factor alpha, thus promoting a retarded tissue repair. Some authors, however, state that despite WBC correlates positively with catabolic cytokines expression and negatively with bone matrix expression, leukocytes possess immunomodulatory function capable of accelerating tissue repair, therefore optimizing the PRP GF effect [13, 26, 27] .
The presence of RBC cells on PRP is not beneficial and can affect its quality. In vivo, RBCs can secrete substances with vasodilatory effect, such as adenosine triphosphate and nitric oxide, the latter is apparently capable of mediating the intensity of action of insulinlike growth factor 1 in diseased cartilage [28] . Another RBC component is hemoglobin. Such a component, under conditions of Means followed by different letters, capital ones on the line and lowercase ones on the column, differ (P < .05). oxidative stress, can release its heme constituent, which is cytotoxic. Iron, another erythrocyte constituent, can catalyze free radicals which induce apoptosis as a reaction to the proinflammatory signaling. Therefore, due to these deleterious effects, PRP must have a limited and small number of erythrocytes in its constitution [29] . It is preferable that PRP holds platelets on a resting state, thus assuring a-granules integrity and consequently, GF viability.
Morphology preservation observed in the present study is described in Table 2 and can also be explained by the centrifugation protocol used because there was no statistical difference between equids or anticoagulants evaluated. Employment of low rpm is directly related to morphology maintenance because centrifugation force influences platelet activation [30] . Control of accelerating and braking speed on centrifugation also plays a vital role because these factors can also be responsible for platelet activation due to its exposure to shear force [18] . The main limitations of the present study relay on the absence of GF determination on PRP samples, the small sample size evaluated, and the absence of a clinical trial using the obtained PRP as a therapeutic tool. Therefore, new studies should be performed to better characterize the differences of PRP quality and its clinical effect on both horses and mules.
Conclusions
CIT was proved to be a better anticoagulant in the reduction of WBC than ACD, on both equids. However, WBC remains a matter of debate, whether if its presence on PRP is beneficial or deleterious. CIT was a better anticoagulant for mules' PRP procurement, due to its promotion of a higher platelet concentration. The protocol employed in the present study was more adequate to concentrate mules' platelets in comparison with horses because it promoted a higher platelet concentration on mules. Development of strategies that promotes tissue regeneration is an effort on both clinical and scientific institutions around the world, especially regarding PRP and its properties. Clinical trials are needed to validate PRP biological effect, especially on mules, due to the poor literature regarding the hybrid's physiology.
